Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
psychiatric drugs
Biotech
AbbVie makes Richter richer, paying $25M to form discovery pact
AbbVie has returned to the source of its antipsychotic powerhouse Vrayla, paying $25 million upfront to form a new discovery pact with Gedeon Richter.
Nick Paul Taylor
Oct 25, 2024 7:55am
AbbVie pens $2B-plus neuro pact with Gilgamesh
May 13, 2024 5:57pm
Headlands acquires Pharmasite to expand mental health trials
Feb 29, 2024 4:20pm
Alto Neuroscience preps IPO to push CNS therapies through clinic
Jan 16, 2024 6:51am
Oryzon med fails to improve borderline personality disorder
Jan 7, 2024 4:17pm
AbbVie pads neuroscience portfolio with $8.7B Cerevel deal
Dec 6, 2023 5:19pm